Gabapentin API Market Opportunities, Growth Trends and Demand Analysis Report 2025-2031

On Nov 7, Global Info Research released "Global Gabapentin API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report includes an overview of the development of the Gabapentin API industry chain, the market status of Gabapentin API Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gabapentin API.

According to our (Global Info Research) latest study, the global Gabapentin API market size was valued at US$ 954 million in 2024 and is forecast to a readjusted size of USD 1327 million by 2031 with a CAGR of 5.0% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
In 2024, the global gabapentin API production is 4,266 tons, with an average price of US8/kg.
Gabapentin API refers to the active pharmaceutical ingredient (API) form of Gabapentin, a medication used to treat epilepsy and various types of nerve pain, such as postherpetic neuralgia. As a white or nearly white crystalline powder, the API is the pure drug substance that is then formulated into the final medicinal product, such as tablets or capsules, for patient use. It works by affecting voltage-gated calcium channels in the brain, reducing abnormal electrical activity and nerve pain.
Gabapentin API is an important neurological drug. It is a gamma-aminobutyric acid (GABA) receptor agonist that reduces neuronal excitability by enhancing the inhibitory effects of GABA. It is widely used in the treatment of epilepsy, neuropathic pain, and anxiety disorders. Its application range is continuously expanding, including migraine, trigeminal neuralgia, and alcohol withdrawal syndrome. Demand for this API continues to grow globally and in China, driven by factors such as an aging population, rising incidence of neurological diseases, and improved medical care.
The upstream supply chain for gabapentin API relies on fine chemicals, primarily benzene compounds and amino acids. 10% of China's benzene compounds are used in gabapentin production; approximately 10% of its annual amino acid production is used in the synthesis of this API. Downstream applications primarily include pharmaceutical preparations for the treatment of epilepsy and neuropathic pain. With approximately 5 million epilepsy patients and 10 million chronic pain sufferers in China, gabapentin, as a first-line drug, holds a significant market share. Pharmaceutical preparations are sold through hospitals, pharmacies, and e-commerce platforms, with online sales growing rapidly.
Future development trends focus on innovation, internationalization, and regulatory compliance. Product innovations include nanocarrier technology, sustained-release formulations, and personalized dosing regimens to enhance bioavailability and therapeutic efficacy. Policy support, such as tax incentives and financial support provided by China's 13th Five-Year Plan for Biopharmaceuticals, is driving technological upgrades in the industry. Technological transformation is expected to increase production by 10% and reduce costs by 15%. However, the industry faces challenges such as patent expirations, generic competition, and medical insurance cost-control policies. Substitution risks arise from competition with drugs such as phenytoin sodium and lamotrigine. Companies need to strengthen industry chain integration, green production, and international compliance (such as FDA certification) to navigate volatility and achieve sustainable development.
This report is a detailed and comprehensive analysis for global Gabapentin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Sample Report Request Gabapentin API
https://www.globalinforesearch.com/reports/2651923/gabapentin-api

Market segment by Type: Below 98%、 Above 98%
Market segment by Application: Epilepsy、 Neuropathic Pain、 Restless Legs Syndrome、 Others
Major players covered: IOL Chemicals and Pharmaceuticals、 Bamboo Pharma、 Jiangxi Synergy Pharmaceutical、 Metrochem、 Suanfarma、 Zeon Pharma、 Amara Labs、 Aspen Biopharma、 Beloor Bayir、 Divi's Laboratories、 Senwayer Century Chemical、 Hikal、 Menadiona、 Saraca Labs、 Zhejiang Chiral Medicine Chemicals、 Zhejiang Excel Pharma、 Anjan Drugs
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa).

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gabapentin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gabapentin API, with price, sales, revenue and global market share of Gabapentin API from 2020 to 2025.
Chapter 3, the Gabapentin API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2020 to 2024.and Gabapentin API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gabapentin API.
Chapter 14 and 15, to describe Gabapentin API sales channel, distributors, customers, research findings and conclusion.

Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.

From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.

Global Info Research
Web: https://www.globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
US: 001-347 966 1888
Email: report@globalinforesearch.com

About Us:
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.

This release was published on openPR.